Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 1.4× sales vs its 2.6× historical median P/S.
Fair value ≈ $8.69 · price $4.51 today
Undervalued · 48% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$STUB StubHub stands out in a crowded ticketing space because it’s purely focused on the resale marketplace, unlike competitors tied to primary ticketing or fragmented platforms. While Live Nation Entertainment (LYV) dominates primary sales, StubHub benefits from being platform-agnostic—pulling inventory across teams, venues, and sellers without conflicts of interest.
Compared to Vivid Seats (SEAT) and Eventbrite (EB), StubHub has stronger global brand recognition and deeper liquidity in high-demand events, which drives better pricing efficiency and repeat buyers. Most of its other competitors like SeatGeek, Gametime, and Viagogo are either private or more niche, lacking the same scale or consistency.
Long term, the live events market continues to grow, and resale demand isn’t going anywhereif anything, it’s becoming more normalized.🔥🔥🔥🔥🔥
$LYV
$SEAT
$EB
$EB Q4 '25 Earnings Results & Recap
Eventbrite reported $291.8M in net revenue and a $10.5M net loss for 2025. Paid ticket volume reached 78.9 million, generating over $3B in gross ticket sales for the year.
$EB $FOSL $GANX $GUTS
All, don’t let this dope try to get everyone to chase another stock like chasing a squirrel. We’re here for one thing and one thing only GANX!!!
12/1-12/5 Top 5 Trend Reason Digest
$SMX : its molecular identity tech was presented at the DMCC Precious Metals Conference in Dubai.
$PLRZ : announcement of a key manufacturing milestone for its proprietary nasal spray product platform.
$EB : definitive agreement for the acquisition by Bending Spoons
$CAPR : Positive Phase 3 HOPE-3 results for deramiocel
$TGL : 1-For-20 Reverse Split & Nasdaq compliance
$EB does this greedy Etrade charge a fee when we sold? I’m on my app and can’t really see much details but I think they did. Just glad to get rid of this stock
